HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

NCT04453436 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2500

Enrollment

OTHER

Sponsor class

Conditions

HIV
Drug
Resistance

Interventions

DRUG: Tenofovir Disoproxil

Sponsor

Federal University of São Paulo

Collaborators

[object Object]